Recently, we and others have reported tyrosine phosphorylation of phospholipase C-3'1 (PLC3,1) enzyme after CD3 activation ofT cells, and have proposed that PLC'yl mediates signal transduction through the T cell receptor (TCR/CD3). Here, using immunoblotting and immune complex PLC assays, we show that CD3 stimulation of Jurkat cells induces the association of PLC3,1 enzyme with CD3 complex. PLC activity is also found to co-precipitate with the CD3~" chain from activated cells. In addition, in vitro PLC assays show that CD3 activation leads to about 10-fold stimulation of PLC't'I activity. These results, along with the observation that Jurkat cells preferentially express PLC3'I, indicate that PLC3,1 participates in CD3 signaling.
S
ignal transduction through the TCR/CD3 complex induces tyrosine phosphorylation of a number of cellular proteins ranging from low to high molecular weights (1) (2) (3) . Inhibition of CD3-induced protein tyrosine kinase activation prevents the successful completion of the mitogenic signal that controls II.-2 production and T cell proliferation (4, 5) . Very little is known about the functional significance of tyrosine phosphorylation of these proteins in T cell activation. Recently, several reports have demonstrated that stimulation of CD3 leads to tyrosine phosphorylation of phospholipase C-'),1 (PLC'yl) enzyme (6) (7) (8) (9) , which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to produce the two second messengers, inositol trisphosphate (IP3) and diacylglycerol. The time course of PLC'y1 tyrosine phosphorylation has been found to correlate with the CD3-induced inositol phosphate formation and the elevation of cytosolic Ca 2+ (6, 7) . Furthermore, we have also shown that stimulation of protein kinase C or of cyclic AMP-dependent protein kinase, which inhibit PI metabolism and Ca z + mobilization in T cells (10) (11) (12) , inhibits PLCT1 tyrosine phosphorylation (6) . On the basis of these observations, it has been suggested that PLCT1 mediates signal transduction via TCR/CD3. The present report supports this hypothesis by demonstrating the stimulation of PLC'y1 activity and the PLC3~I/CD3 association after ligand binding to the CD3 structure.
Materials and Methods
Cells ,z~ Reagen~ Human leukemic T cell line, Jurkat, was maintained in media (KPMI 1640, 10% FCS, 50 U/ml penicillin, 50 #g/ml streptomycin, 2 raM t-glutamine) at a density of 1-2 x 10 s cells/ml, and the media were changed after every 2 d.
Cell Lysis and lramunoprecipitation. Cells were lysed (40 rain, 4~ in 1% Triton X-100 and 10% glycerol solution in 50 mM Trizma, pH 7.4, with 150 mM NaC1, 1 mM PMSF, 0.26 U/ml of aprofinin, 1 mM Na-orthovanadate, 20 mM NaF, and 20 mM sodium pyrophosphate. Precleared lysates were subjected to immunoprecipitation with appropriate antibodies (Abs) and immune complexes were washed as described by us previously (6) .
lmraunoblotting. Proteins in imraunoprecipitates or cell lysates were subjected to SDS-PAGE and then transferred to nitrocellulose membranes to blot with appropriate Abs as described (6) . These blots were developed with either nSI-protein A or l~I-goat anti-mouse IgG Ab (0.4--0.5 #Ci/ml; ICN Chemicals, Irvine, CA) for 2 h at room temperature. After washing, these blots were exposed to Kodak x-ray films for autoradiography.
Immunecomplex Phospholipase C Assay. These assays were performed as described by us previously (6) .
Results end Discussion
In vitro measurements of PLC activity show that antiphosphotyrosine (APTyr) Ab isolates ~10-fold or more of the activity from stimulated T cells as compared with that from nonstimulated cells (6) (7) (8) . Maximal activity is obtained within 2 rain of CD3 activation, followed by a subsequent reduction after 10 min (6). Since changes in APTyr Ab-bound PLC activity have been found to correlate with alterations in the level of PLCT1 tyrosine phosphorylation and the degree of CD3-induced Ca 2 + mobilization (6), this enzyme has been proposed to mediate the signal transduction via the TCR/CD3 structure.
To demonstrate the direct participation of PLC3,1 in T cell activation, it was decided first of all to examine if the APTyr Ab-bound PLC activity was due to PLC~/1. To achieve this, CD3-activated Jurkat cells were lysed and then subjected to immunoprecipitation with APTyr Ab. The presence of PLC3d in these immune complexes was detected by immunoblotting with an anti-PLC3d Ab. From parallel samples PLC'yl was also immunoisolated and subjected to similar analysis. These experiments demonstrate that APTyr Ab used in PLC assays binds to PLC3'I enzyme (Fig. 1, lane B) . Since these experiments were performed with excess amounts of APTyr and anti-PLC'y1 Abs, comparison of counts present in PLCqd bands (lanes B vs. D) indicates that ~g5% of the cellular PLC~/1 enzyme is precipitated with APTyr Ab. However, under similar conditions of precipitation, PLC'y1 present in APTyr Ab immunoprecipitate accounts for 60-70% of the total PLC~,I activity from stimulated T cells. For example, a representative experiment shows that PLC~/1 isolated from 3 min-activated Jurkat cells (5 x 106 cells/sample) using anti-PLC3,1 and APTyr Abs produces 4,162 and 3,050 pmols oflP3 in 30 min, respectively. This indicates that CD3-induced tyrosine phosphorylation of PLC'y1 enhances its enzymatic activity.
To further examine the stimulation of PLC~/1 activity after CD3 activation, the enzyme was precipitated from activated and nonactivated cells, and PLC activities were measured. As described in the case of EGF receptor stimulation (14), we detected CD3-mediated stimulation of PLC3d activity. The enzyme isolated from activated T cells has 1.3-1.7 times higher activity than the one from nonactivated cells (Table 1 ) (n = 4). Maximal stimulation of enzyme activity was detected within 2 min of CD3 activation, which gradually decreases to the control level. Therefore, considering that ,v5% of the cellular PLC~/1 is tyrosine phosphorylated, the present data demonstrate 7-15%-fold stimulation of PLC3,1 activity after CD3 activation. Taken together, these results indicate an involvement of PLC~/1 in TCR signaling. The ligand binding to epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) receptors have been shown to promote PLC3' association with the receptors (15) (16) (17) . In our experiments, association of PLC activity with the CD3 structure was first indicated by the observation that, within 2-3 min of activation, a low but significant amount of PLC activity (180-340 pmol IP3 formed/30 min) was precipitated by anti-CD3~'Ab (n = 4). CD3~'protein forms a complex with TCR/CD3 and apparently plays a crucial role in signal transduction (18) . However, variable results were obtained when CD3-anti-CD3 complexes, isolated from the activated cell lysates, were tested for the presence of PLC activity. This variation could be due to relatively weak binding and a rapid dissociation of OKT3 Ab from CD3 at 37~ (19) . Therefore, instead of adding anti-CD3 to T cells at 37~ precooled T cells were coated with OKT3 Ab at 4~ for 7-8 min, where the binding is largely bivalent, complete, and stronger (19) . The precoated cells were then transferred to 37~ to induce CD3 stimulation. Using this procedure, PLC activity was found to co-precipitate with the CD3 structure in a reproducible manner (n = 6). The level of activity associated with the CD3 complex after 4-6 min of activation ranges from 478 to 805 pmol of IP3 formed/30 min (n = 4). The data from a representative experiment are shown in Fig. 2 A. In parallel experiments, APTyr Ab precipitated a high level of PLC activity from cell lysates (Fig. 2 B) (n = 4), consistent with the increased PLC3,1 tyrosine phosphorylation (data not shown). Similar experiments performed with anti-CD45RO Ab, UCHL1, do not show precipitation of PLC activity with CD45KO Ag, indicating a specific association of PLC activity with the CD3 structure.
To determine if this activity is due to PLC3,1, CD3 complexes immunoprecipitated from the lysates of activated T cells were subjected to SDS-PAGE, and the presence of PLC3~I was detected by immunoblotting with anti-PLC~/1 Ab. Fig. 3 shows that CD3 complex from activated cells conrains PLC'y1 (lane C-'). Radioactive counts present in the PLC'y1 protein band precipitated with CD3 complex from 3 x 107 Jurkat cells (Fig. 3, lane C) are about one half of that in PLCqrl from 6 x l0 s Jurkat cell lysate (Fig. 3, lane B) , indicating ,vl% of the cellular PLC~/1 in association with the CD3 structure.
The present work demonstrates that CD3 activation of T cells leads to the association of PLC~/1 enzyme with the CD3 complex and also stimulates its enzymatic activity. These results, along with the observation that Jurkat cells preferentially express PLC~I and not PLC3,2 (results not shown), indicate that the former isozyme of PLC mediates TCR/CD3 signaling. Although in comparison with EGF and PDGF receptor stimulation, the extent of CD3-induced PLC3~I tyrosine phosphorylation and its association with the CD3 complex is small, these values appear consistent when the density of CD3 on T cells (2 x 104/cell; reference 19) is compared with that of EGF or PDGF receptors (1.5-5 x 10S/cell; reference 20). The CD3/PLC3,1 association observed in activated cells apparently indicates that CD3-1inked protein tyrosine kinase p59~ (1) may be responsible for PLC3,1 tyrosine phosphorylation. However, a fairly high level of PLC3,1 tyrosine phosphorylation occurs before a significant CD3/PLC3,1 association (Fig. 2) , suggesting that in T cells increased tyrosine phosphorylation of PLC3,1 does not correlate with its association with the CD3 structure. Similar observations were made in NIH3T3 cells where, despite low levels of tyrosine phosphorylation, mutant PLC3,1 associates with the PDGF receptor (21) . On the contrary, in HER14 cells PDGFmediated PLC3,1 tyrosine phosphorylation does not induce EGF receptor/PLC3,1 association (20) . These studies suggest that the association of PLC3,1 with receptor molecules depends upon the biochemical state of the latter, perhaps determined by their phosphorylation. Therefore, the question to be addressed is whether the cytosolic or the TCR/CD3-bound protein tyrosine kinase phosphorylates PLC3,1 after CD3 activation of T cells.
